期刊文献+

细胞药物的标准及质量控制——细胞药物连载之四 被引量:3

The Standards and Quality Control of Cell Drug
原文传递
导出
摘要 细胞药物最终用于人体,必须建立相应的质量标准,进行质量控制。系统地贯彻到供者筛查、组织采集、细胞分离、培养、冻存、复苏、放行、运输、使用等全过程,确保产品的安全性、有效性和稳定性。近年来,我国逐渐改变了把细胞治疗作为第三类医疗技术管理的思路。一方面,已有第三类医疗技术取消行政审批;另一方面,又把除自体外的干细胞移植纳入药物管理,并建立了相应的质量标准和质量管理办法。 Cell drugs are eventually used in the human body,it is necessary to establish corresponding standards for quality control. To ensure the safety,effectiveness and stability of the product,the whole process of donor screening,tissue collection,cell separation,cell culture,cell cryopreservation,cell resuscitation,check out,transport and application must be systematically carried out. In recent years,China has gradually changed the management ideas of treating the cell therapy as the third level medical technology. On the one hand,the administrative examination and approval of already existing third level medical technology are currently cancelled.And on the other hand, stem cell transplantations are managed as drug except for autologous stem cell transplantation,and the corresponding standards and management method of quality have already been established.
作者 王佃亮
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2016年第10期115-121,共7页 China Biotechnology
关键词 细胞药物 干细胞 质量标准 质量控制 质量管理 第三类医疗技术 Cell drug Stem cell Quality standards Quality control Quality administration The third level medical technology
  • 相关文献

参考文献21

  • 1Domen J,Christensen J L,Gille D,et al.Cryopreserved ex vivoexpanded allogeneic myeloid progenitor cell product protects neutropenic mice from a lethal fungal infection.Cell Transplant,2016,25(1):17-33.
  • 2Dergacheva T I,Lykov A P,Shurlygina A V,et al.Parameters of microcirculation in the broad ligament of the uterus in Wistar rats after injection of autologous biomedical cell product.Bull Exp Biol Med,2015,159(6):786-788.
  • 3Zhang W,Smythe J,Frith E,et al.An innovative method to generate a good manufacturing practice-ready regulatory T-cell product from non-mobilized leukapheresis donors.Cytotherapy,2015,17(9):1268-1279.
  • 4Bachier C,Potter J,Potter G,et al.High white blood cell concentration in the peripheral blood stem cell product can induce seizures during infusion of autologous peripheral blood stem cells.Biol Blood Marrow Transplant,2012,18(7):1055-1060.
  • 5Lasala G P,Silva J A,Minguell J J.Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product.J Thorac Cardiovasc Surg,2012,144(2):377-382.
  • 6Wright C,Velickovic Z,Brown R,et al.Raising the standard:changes to the Australian Code of Good Manufacturing Practice(c GMP)for human blood and blood components,human tissues and human cellular therapy products.Pathology,2014,46(3):177-183.
  • 7Jones M,Varella-Garcia M,Skokan M,et al.Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System.Cytotherapy,2013,15(11):1323-1339.
  • 8Dominici M,Le Blanc K,Slaper-Cortenbach I,et al.Minimal criteria for defining multipotent mesenchymal stromal cells.The International Society for Cellular Therapy position statement.Cytotherapy,2006,8:315-331.
  • 9Volpe G,Delibato E,Fabiani L,et al.Development and evaluation of an ELIME assay to reveal the presence of Salmonella in irrigation water:comparison with real-time PCR and the standard culture method.Talanta,2016,149:202-210.
  • 10Dufrane D,Docquier P L,Delloye C,et al.Scaffold-free threedimensional graft from autologous adipose-derived stem cells for large bone defect reconstruction:Clinical proof of concept.Medicine(Baltimore),2015,94(50):e2220.

同被引文献22

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部